Achieve Life Sciences highlights cytisinicline path to FDA approval, commercial launch in corporate presentation
Reuters2026/09/02 21:14- Achieve Life Sciences investor presentation outlined plans to push smoking-cessation drug cytisinicline toward US approval, with a PDUFA date of Jun 20, 2026.
- Phase 3 pooled data showed continuous abstinence of 31.5% vs 8.2% on placebo at weeks 9-12; odds ratio 5.3.
- At weeks 9-24, pooled continuous abstinence was 20.8% vs 4.5%; odds ratio 5.5.
- Financing package totals up to $354 million, including $180 million upfront and up to $174 million in FDA-approval-triggered warrants.
- Commercial buildout highlighted hires from Verona Pharma’s Ohtuvayre launch team, positioning for a potential US launch in Q4 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rapid7 director Julian Wendell Waits Sr. files initial beneficial ownership statement
Fertilizantes Heringer seeks court-backed mediation, asks for stay on creditor actions
A wave of “anti-data center” sentiment sweeps across the US, with Besent blaming cloud giants for not knowing how to win hearts and minds.
U.S. Treasury Secretary Yellen has publicly "called out" major tech giants, criticizing them for "turning a deaf ear" to community sentiment amid the explosive expansion of AI infrastructure, and rating their public relations performance only at a D-. The construction of data centers is driving up electricity and memory costs, while waves of community resistance are intensifying. Yellen's criticism of hyperscale cloud providers has extended from their debt structures to their media strategies, and the Trump administration may escalate policy pressure on AI tech giants.
Microsoft (MSFT.US) makes major changes to its financial reporting framework! Azure quarterly revenue revealed for the first time, surpassing 29 billion in a single quarter
Microsoft will begin disclosing the quarterly sales of its Azure cloud division to increase transparency. The company has provided the past two years of quarterly Azure revenue data, showing continuous growth, with the most recent quarter reaching $29.4 billion.
Crypto prices
More
